Global Alliance for TB Drug Development Inc
Tb alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
Global Alliance for TB Drug Development Inc at a glance
In short: Global Alliance for TB Drug Development Inc reported $360K in grants paid in 2024 (a total; its filing lists no individual grants). Source: 2024 IRS Form 990.
- Grants paid (2024)
- $359,938 — reported as a total on the IRS filing, without an itemized list
- +2299.6% vs 2023
- Total assets
- $204,316,428
- +3.5% vs 2023
- Revenue (2024)
- $63,732,557
- +5.8% vs 2023
- Net investment income (2024)
- $9,675,203
- +18.2% vs 2023
- Expenses (2024)
- $61,508,783
- +11.1% vs 2023
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated September 2026.
Who Global Alliance for TB Drug Development Inc funds
How this funder distributes its grants
Grant Size Distribution
1 grant across all recorded years
The most common grant size was under $50K: 1 grant of 1 (100%).
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $15K (2023) to $360K (2024). In 2024 it reported $360K in grants paid, as a total without an itemized list.
Hatched bars: grants paid as reported on the IRS filing, which lists no individual grants for that year.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| National TB Controllers Association Atlanta, GA | Comm. Engage | $15,000 |
Ready to take the next step with Global Alliance for TB Drug Development Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $204,316,428 | $63,732,557 | $61,508,783 | $359,938 | Total only | $9,675,203 |
| 2023 | $197,319,541 | $60,240,486 | $55,378,579 | $15,000 | 1 | $8,182,816 |
| 2022 | $176,686,879 | $56,212,963 | $55,785,890 | $263,496 | Total only | $2,631,898 |
| 2021 | $187,560,796 | $58,653,379 | $57,430,605 | $353,118 | Total only | $63,272 |
| 2020 | $191,155,661 | $61,267,452 | $61,720,389 | $336,204 | Total only | $952,541 |
"Total only": grants paid as reported on the IRS filing, which lists no individual grants for that year.
About Global Alliance for TB Drug Development Inc
Based on IRS filings
Global Alliance for TB Drug Development Inc is a public charity focused on Medical Research, based in New York, NY. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $204.3M in total assets. In 2024, it reported $360K in grants paid as a total on its IRS filing, without an itemized list. Net investment income was $9.7M.
Focus Areas
Leadership & Key People
Officers and directors from IRS filings
Global Alliance for TB Drug Development Inc is led by Melvin Spigelman, President & CEO on every filing since 2020; 12 of 23 officers listed in 2024 are compensated.
Officers on the 2024 filing
Melvin Spigelman
President & CEO
On filings since 2020
45 hrs/week
$964K (2020) → $940K (2024)
David Norton
Chair
Director → Chair, 2023
On filings since 2021
3 hrs/week
No compensation reported
Salah Foraida
Senior Director & Medical Affairs
On filings since 2022
45 hrs/week
$408K (2022) → $430K (2024)
Mitchell Warren
Director
On filings since 2020
3 hrs/week
No compensation reported
Eric Goosby
Director
On filings since 2021
3 hrs/week
No compensation reported
Sundar Kodiyalam
Director
On filings since 2021
3 hrs/week
No compensation reported
Kim Schwartz
Director
On filings since 2022
3 hrs/week
No compensation reported
Rasha Hibri
Director
On filings since 2022
3 hrs/week
No compensation reported
Ratan Watal
Director
On filings since 2023
3 hrs/week
No compensation reported
Akshay Vaishnaw
Director
New on the 2024 filing
3 hrs/week
No compensation reported
Ann Taylor
Director
New on the 2024 filing
3 hrs/week
No compensation reported
Srishti Gupta
Director
New on the 2024 filing
3 hrs/week
No compensation reported
Angela Vanderploeg
Treasurer & CFO
On filings since 2020
45 hrs/week
$412K (2020) → $422K (2024)
Colleen Pero
Secretary & CAO
On filings since 2020
45 hrs/week
$455K (2020) → $470K (2024)
Eugene Sun
Senior Vice President, Research & Development
Senior Vice President, R & D → Senior Vice President, Research & Dev't, 2022
Senior Vice President, Research & Dev't → Senior Vice President, Research & Development, 2024
On filings since 2020
45 hrs/week
$488K (2020) → $581K (2024)
Kathleen Schostack
Senior Vice President, Program & Alliance Management
Vice President, Program & Alliance Management → Senior Vice President, Program & Alliance Management, 2021
On filings since 2020
45 hrs/week
$376K (2020) → $432K (2024)
Nader Fotouhi
Senior Vice President & Chief Scientific Officer
Chief Scientific Officer → Senior Vice President & Chief Scientific Officer, 2023
On filings since 2020
45 hrs/week
$550K (2020) → $565K (2024)
Robert Lorette
Senior Vice President & Business Development
On filings since 2020
45 hrs/week
$435K (2020) → $449K (2024)
Sandeep Juneja
Senior Vice President & Market Access
On filings since 2020
45 hrs/week
$410K (2020) → $418K (2024)
Rajneesh Taneja
Vice President & Pharmaceutical Product Development
Vice President & Pharmaceutical Product Development → Vice President & Pharmaceutical Prod. Dev't, 2023
Vice President & Pharmaceutical Prod. Dev't → Vice President & Pharmaceutical Product Development, 2024
On filings since 2021
45 hrs/week
$346K (2021) → $371K (2024)
Maria Beumont
Vice President & Chief Medical Officer
On filings since 2022
45 hrs/week
$380K (2022) → $498K (2024)
Pietro O. Turilli
Senior Vice President & External Affairs
Sr.vp & Ext Aff → Sr.vp & External Affairs, 2023
Sr.vp & External Affairs → Senior Vice President & External Affairs, 2024
On filings since 2022
45 hrs/week
$161K (2022) → $369K (2024)
Ariel Pablos-Mendez
Vice Chair
Director → Vice Chair, 2023
On filings since 2020
3 hrs/week
No compensation reported
Former officers (11)
- Former: Mario Raviglione (2020–2023) — Director
- Former: Bruce Carter (2020–2022) — Chairman
- Former: Jane Griffiths (2020–2022) — Director
- Former: Paul Bruinenberg (2020–2022) — Senior Medical Officer
- Former: Shalini Sharp (2020–2022) — Director
- Former: Sangita Reddy (2021–2022) — Director
- Former: Nancy Miller-Rich (2021) — Director
- Former: Daniel Everitt (2020) — Senior Medical Officer & Vice President
- Former: Jan Landberg (2020) — Director
- Former: Nancy Miller Rich (2020) — Director
- Former: Willo Brock (2020) — Senior Vice President & External Affairs
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $940K, to Dr Melvin Spigelman (President/CEO). 12 officers or directors reported compensation on that filing.
Frequently asked questions about Global Alliance for TB Drug Development Inc
How much does Global Alliance for TB Drug Development Inc give each year?
Global Alliance for TB Drug Development Inc reported $360K in grants paid in 2024 on its 2024 IRS Form 990, as a total without an itemized list of grants. In 2023 it gave $15K across 1 grant.
How large is Global Alliance for TB Drug Development Inc?
Global Alliance for TB Drug Development Inc reported $204.3M in total assets on its 2024 IRS Form 990. Its revenue that year was $63.7M.
What is Global Alliance for TB Drug Development Inc?
Global Alliance for TB Drug Development Inc is a public charity focused on Medical Research, based in New York, NY. It holds $204.3M in total assets as of 2024.
Where does Global Alliance for TB Drug Development Inc operate?
Global Alliance for TB Drug Development Inc has awarded grants in Georgia.
What is Global Alliance for TB Drug Development Inc's EIN?
Global Alliance for TB Drug Development Inc's EIN (Employer Identification Number) is 13-4128413. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS October 14, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS October 19, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 1, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS October 3, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS October 23, 2025)
- IRS filings on file for fiscal years 2020–2024
Explore Open Grants
Browse active grant opportunities in Global Alliance for TB Drug Development Inc's focus areas in our free grants database
Similar Funders
Similar funders in New York
The Ford Foundation
New York, NY
The Ford Foundation funds organizations and initiatives working to reduce inequality and advance social justice, including work on civic engagement, civil rights, climate justice, disability rights, and technology and society. In 2024, its grants ranged from $45 to $15 million, with a median of $100,000, supporting work in the U.S. and internationally. It says most grants are identified by the foundation and it does not accept unsolicited proposals by mail, email, or phone; limited opportunities may be offered separately.
Assets
$17.5B
Grants
4,007
Total Given
$844.7M
The New York Community Trust
New York, NY
The New York Community Trust funds nonprofit programs in areas such as arts, education, health, the environment, workforce development, and youth development, including projects that improve services, build organizational capacity, or advance policy and systems change. Its competitive grants mainly serve New York City, Long Island, and Westchester, with some national and international environmental funding; the 2024 median grant was $20,000. The profile does not state whether it accepts unsolicited requests.
Assets
$3.5B
Grants
2,748
Total Given
$193.8M
The Simons Foundation Inc
New York, NY
The Simons Foundation funds research and public engagement in mathematics and the physical, life, autism, and neuroscience sciences. In 2024, it made 1,727 grants, with a median award of $72,000 and amounts ranging from $1,480 to $20 million, supporting organizations in the U.S. and internationally. It states that it funds only preselected charitable organizations and does not accept unsolicited requests.
Assets
$4.5B
Grants
1,727
Total Given
$272.0M
Local Initiatives Support Corporation
New York, NY
LISC funds affordable housing, community development, small businesses, and related efforts that strengthen inclusive communities, providing grants as well as loans, equity, and technical assistance across the country. Its 2024 grants had a median award of $40,000, though amounts varied widely. Application access is program-specific: for its Rhode Island child care facilities planning grants, applicants are instructed to consult program staff before submitting a request.
Assets
$1.6B
Grants
1,119
Total Given
$102.8M
Wellspring Philanthropic Fund Inc
New York, NY
Wellspring Philanthropic Fund supports human rights and social and economic justice, including work on climate, the environment, civic engagement, and Jewish causes, in the United States and internationally. Its 2024 grants had a median of $200,000, with amounts ranging from $500 to $9.75 million. It funds only preselected organizations and does not accept unsolicited requests; it plans to end grantmaking by the end of 2028.
Assets
$134.4M
Grants
1,101
Total Given
$326.0M
More Funders in New York
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from Global Alliance for TB Drug Development Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Global Alliance for TB Drug Development Inc down — hundreds of funders to go?